Skip to main content
Premium Trial:

Request an Annual Quote

GNS Names New VP; Human Genome Sciences Hires New CFO; Clinical Data Expands Cogenics Leadership; and Others

NEW YORK (GenomeWeb News) - Zach Pitluk joined Gene Network Sciences as vice president of business development.
 
Pitluk moved to Gene Network Sciences from Definiens, where he served as the North America life sciences business manager.  Previously, he spent five years at Cellomics, a Fischer Biosciences business unit. Prior to Cellomics, he held sales positions at Clontech Labs, Bristol-Myers Squibb, and ISCO.
 
He received his PhD in molecular biophysics and biochemistry from Yale University.

Human Genome Sciences named Timothy Barabe as its new senior vice president and chief financial officer.
 
Barabe will also serve on the Management Committee.
 
Most recently, Barabe spent two years with UK-based Regent Medical as CFO. Prior to that, he held executive positions within Novartis and was CFO of Sandoz's generics business unit in Vienna, Austria. He was group vice president and CFO of CIBA Vision and director of corporate finance at Ciba-Geigy prior to its acquistion by Novartis.
 
Barabe received his MBA in finance from the University of Chicago and his BBA in finance from the University of Massachusetts.

Clinical Data appointed Robert Bondaryk as general manager and unit head of Cogenics, and Abdul Ally as Cogenics' vice president of laboratory operations, Clinical Data said this week.
 
Formerly an executive vice president and general manager of business development at Proteome Systems, Bondaryk also spent time as vice president of life science and drug discovery at Fischer Scientific. He was vice-president of corporate development at Pharm-Eco Laboratories, co-founder and president of Medtech Capital, and senior consultant at Arthur D. Little.
 
Bondaryk received his PhD in biochemistry and MSc in molecular biology from Harvard University. He has an BA inbilogy from Bowdoin College in Maine.

Promoted? Changing jobs? GenomeWeb News wants to know. E-mail us at [email protected] to announce your move in PEOPLE, a weekly roundup of personnel changes in the genomics industry.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.